Abrenica, Jayson .

HRN: 20-85-91  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/15/2022
07/21/2022
IVT
165mg
Q6
Pcap
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: